OmnicellOMCL
About: Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
Employees: 3,590
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
1,039% more call options, than puts
Call options by funds: $38.5M | Put options by funds: $3.38M
70% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 30
44% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 73
7% more funds holding
Funds holding: 258 [Q3] → 276 (+18) [Q4]
4% more capital invested
Capital invested by funds: $1.99B [Q3] → $2.06B (+$72.9M) [Q4]
0.68% more ownership
Funds ownership: 99.13% [Q3] → 99.81% (+0.68%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Wells Fargo Stan Berenshteyn 0% 1-year accuracy 0 / 9 met price target | 26%upside $38 | Equal-Weight Maintained | 17 Apr 2025 |
JP Morgan Anne Samuel 53% 1-year accuracy 18 / 34 met price target | 19%upside $36 | Neutral Maintained | 20 Mar 2025 |
Benchmark Bill Sutherland 33% 1-year accuracy 14 / 43 met price target | 105%upside $62 | Buy Maintained | 4 Feb 2025 |
Financial journalist opinion
Based on 3 articles about OMCL published over the past 30 days
